Use of Psychopharmacological Agents for Functional Gastrointestinal Disorders

Overview

Journal Gut

Specialty Gastroenterology

Date 2005 Aug 16

PMID 16099800

Citations 24

Authors

R E Clouse

P J Lustman

Affiliations

Soon will be listed here.

Citing Articles

Abdominal and Pelvic Pain: Current Challenges and Future Opportunities.

Yuan T, Greenwood-Van Meerveld B Front Pain Res (Lausanne). 2022; 2:634804.

PMID: 35295470 PMC: 8915637. DOI: 10.3389/fpain.2021.634804.

Somatization in patients with predominant diarrhoea irritable bowel syndrome: the role of the intestinal barrier function and integrity.

Prospero L, Riezzo G, Linsalata M, Orlando A, DAttoma B, Di Masi M BMC Gastroenterol. 2021; 21(1):235.

PMID: 34022802 PMC: 8141183. DOI: 10.1186/s12876-021-01820-7.

Psychedelic-assisted therapy for functional neurological disorders: A theoretical framework and review of prior reports.

Stewart B, Dean J, Koek A, Chua J, Wabl R, Martin K Pharmacol Res Perspect. 2020; 8(6):e00688.

PMID: 33280274 PMC: 7719191. DOI: 10.1002/prp2.688.

Efficacy of a high-dose proton pump inhibitor in patients with gastroesophageal reflux disease: a single center, randomized, open-label trial.

Cho J, Shin C, Yoon H, Park Y, Kim N, Lee D BMC Gastroenterol. 2020; 20(1):275.

PMID: 32811427 PMC: 7433117. DOI: 10.1186/s12876-020-01410-z.

Efficacy and safety of pinaverium bromide combined with flupentixol-melitracen for diarrhea-type irritable bowel syndrome: A systematic review and meta-analysis.

Qin L, Qin J, Yang Q, Lv X, Huang L Medicine (Baltimore). 2019; 98(2):e14064.

PMID: 30633208 PMC: 6336559. DOI: 10.1097/MD.0000000000014064.

References

Prakash C, Clouse R . Long-term outcome from tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci. 2000; 44(12):2373-9. DOI: 10.1023/a:1026645914933. View

Mertz H . Irritable bowel syndrome. N Engl J Med. 2003; 349(22):2136-46. DOI: 10.1056/NEJMra035579. View

Yerevanian B, Koek R, Feusner J, Hwang S, Mintz J . Antidepressants and suicidal behaviour in unipolar depression. Acta Psychiatr Scand. 2004; 110(6):452-8. DOI: 10.1111/j.1600-0447.2004.00437.x. View

Spiller R . Treatment of Irritable Bowel Syndrome. Curr Treat Options Gastroenterol. 2003; 6(4):329-337. DOI: 10.1007/s11938-003-0025-6. View

Rollman B, Block M, Schulberg H . Symptoms of major depression and tricyclic side effects in primary care patients. J Gen Intern Med. 1997; 12(5):284-91. PMC: 1497108. DOI: 10.1046/j.1525-1497.1997.012005284.x. View

Siproudhis L, Dinasquet M, Sebille V, Reymann J, Bellissant E . Differential effects of two types of antidepressants, amitriptyline and fluoxetine, on anorectal motility and visceral perception. Aliment Pharmacol Ther. 2004; 20(6):689-95. DOI: 10.1111/j.1365-2036.2004.02151.x. View

Creed F, Fernandes L, Guthrie E, Palmer S, Ratcliffe J, Read N . The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology. 2003; 124(2):303-17. DOI: 10.1053/gast.2003.50055. View

Riley 3rd J, Robinson M, Kvaal S, Gremillion H . Effects of physical and sexual abuse in facial pain: direct or mediated?. Cranio. 1999; 16(4):259-66. DOI: 10.1080/08869634.1998.11746066. View

Miller A, North C, Clouse R, Wetzel R, Spitznagel E, Alpers D . The association of irritable bowel syndrome and somatization disorder. Ann Clin Psychiatry. 2001; 13(1):25-30. DOI: 10.1023/a:1009060731057. View

10.

Clouse R . Managing functional bowel disorders from the top down: lessons from a well-designed treatment trial. Gastroenterology. 2003; 125(1):249-53. DOI: 10.1016/s0016-5085(03)00808-4. View

11.

Boyer E, Shannon M . The serotonin syndrome. N Engl J Med. 2005; 352(11):1112-20. DOI: 10.1056/NEJMra041867. View

12.

Tack . Functional Dyspepsia: Impaired Fundic Accommodation. Curr Treat Options Gastroenterol. 2000; 3(4):287-294. DOI: 10.1007/s11938-000-0042-7. View

13.

Kroenke K, Spitzer R, deGruy 3rd F, Hahn S, Linzer M, Williams J . Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry. 1997; 54(4):352-8. DOI: 10.1001/archpsyc.1997.01830160080011. View

14.

Hudson J, Mangweth B, Pope Jr H, De Col C, Hausmann A, Gutweniger S . Family study of affective spectrum disorder. Arch Gen Psychiatry. 2003; 60(2):170-7. DOI: 10.1001/archpsyc.60.2.170. View

15.

Jackson J, OMalley P, TOMKINS G, Balden E, Santoro J, Kroenke K . Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med. 2000; 108(1):65-72. DOI: 10.1016/s0002-9343(99)00299-5. View

16.

OMalley P, Jackson J, Santoro J, TOMKINS G, Balden E, Kroenke K . Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract. 2000; 48(12):980-90. View

17.

Ritchie J, TRUELOVE S . Comparison of various treatments for irritable bowel syndrome. Br Med J. 1980; 281(6251):1317-9. PMC: 1714728. DOI: 10.1136/bmj.281.6251.1317. View

18.

Camilleri M, Heading R, Thompson W . Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther. 2002; 16(8):1407-30. DOI: 10.1046/j.1365-2036.2002.01305.x. View

19.

Gill D, Hatcher S . Antidepressants for depression in people with physical illness. Cochrane Database Syst Rev. 2000; (2):CD001312. DOI: 10.1002/14651858.CD001312. View

20.

McQuay H, TRAMER M, Nye B, Carroll D, Wiffen P, Moore R . A systematic review of antidepressants in neuropathic pain. Pain. 1996; 68(2-3):217-27. DOI: 10.1016/s0304-3959(96)03140-5. View